本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Aligos Therapeutics, Inc.

7.04
+0.08001.15%
盤前6.87-0.1700-2.41%08:00 EDT
成交量:5.79萬
成交額:40.93萬
市值:4,356.21萬
市盈率:-2.87
高:7.36
開:7.06
低:6.82
收:6.96
52周最高:13.69
52周最低:3.76
股本:618.78萬
流通股本:300.20萬
量比:1.44
換手率:1.93%
股息:- -
股息率:- -
每股收益(TTM):-2.4500
每股收益(LYR):-2.4500
淨資產收益率:-196.92%
總資產收益率:-69.33%
市淨率:0.81
市盈率(LYR):-2.87

資料載入中...

2022/08/04

重要事件披露

8-K - Current report
2022/08/04

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/06/27

重要事件披露

8-K - Current report
2022/05/04

重要事件披露

8-K - Current report
2022/05/04

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/03/30

重要事件披露

8-K - Current report
2022/03/22

重要事件披露

8-K - Current report
2022/03/10

重要事件披露

8-K - Current report
2022/03/10

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/10

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/04

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/04

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/31

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership